Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

Duminuco A, Leotta D, Allegra A, Caracciolo D, Caruso L, Chiarenza A, Del Fabro V, Di Martina V, Figuera A, Fiumara PF, Gentile M, Innao V, Mancuso S, Martino EA, Mosca A, Motta G, Pedalino F, Rossi M, Stagno F, Tona G, Di Raimondo F, Palumbo GA

Open source

DOI: 10.1111/bjh.70638
Published: 2026 Sep
Container: British journal of haematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70638,
  title = {Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.},
  author = {Duminuco A and Leotta D and Allegra A and Caracciolo D and Caruso L and Chiarenza A and Del Fabro V and Di Martina V and Figuera A and Fiumara PF and Gentile M and Innao V and Mancuso S and Martino EA and Mosca A and Motta G and Pedalino F and Rossi M and Stagno F and Tona G and Di Raimondo F and Palumbo GA},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70638},
  url = {https://doi.org/10.1111/bjh.70638}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.
AU  - Duminuco A
AU  - Leotta D
AU  - Allegra A
AU  - Caracciolo D
AU  - Caruso L
AU  - Chiarenza A
AU  - Del Fabro V
AU  - Di Martina V
AU  - Figuera A
AU  - Fiumara PF
AU  - Gentile M
AU  - Innao V
AU  - Mancuso S
AU  - Martino EA
AU  - Mosca A
AU  - Motta G
AU  - Pedalino F
AU  - Rossi M
AU  - Stagno F
AU  - Tona G
AU  - Di Raimondo F
AU  - Palumbo GA
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70638
UR  - https://doi.org/10.1111/bjh.70638
ER  -

APA

A, D., D, L., A, A., D, C., L, C., A, C., V, D. F., V, D. M., A, F., PF, F., M, G., V, I., S, M., EA, M., A, M., G, M., F, P., M, R., F, S., G, T., F, D. R., & GA, P. (2026). Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.. British journal of haematology. https://doi.org/10.1111/bjh.70638

Source records

pubmed · retrieved 2026-09-26T09:33:55.817Z